Valuation — not yet established
No valuation for Bright Peak Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($244.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Bright Peak Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Later Stage VC (Series C) | $90.0M | ▮ | ▮ |
| Jun 2021 | Early Stage VC (Series B) | $107.0M | ▮ | ▮ |
How Bright Peak Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bright Peak Therapeutics, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- How much has Bright Peak Therapeutics raised?
- Bright Peak Therapeutics has raised $244.0M in total funding across 2 recorded rounds.
- When did Bright Peak Therapeutics last raise?
- Bright Peak Therapeutics last raised in Jun 2024 (Later Stage VC (Series C)), raising $90.0M.